Hans Gelderblom
Leiden University Medical Center · Leiden University Medical Centre · LUMC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hans Gelderblom as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:08 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03620149 · Reduced Dose-density of Denosumab for Unresectable GCTBEuropean Organisation for Research and Treatment of Cancer - EORTC · terminated · Bone Giant Cell Tumor · study chair
- Ph3NCT02929394 · Trabectedin Maintenance Post 1st-line in STSEuropean Organisation for Research and Treatment of Cancer - EORTC · terminated · Sarcoma, Soft Tissue · study chair
- Ph2NCT02821507 · Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaLeiden University Medical Center · completed · Conventional Chondrosarcoma, Myxoid Liposarcoma, Mesenchymal Chondrosarcoma · principal investigator
- Ph1NCT01743300 · The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer PatientsLeiden University Medical Center · completed · Healthy · principal investigator
- Ph3NCT01265810 · Caphosol in Oral Mucositis Due to Targeted TherapyImpaqtt Foundation · completed · Oral Complaints, Renal Cell Carcinoma, Hepatocellular Carcinoma · study chair
- Ph2NCT01190462 · Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal CancerLeiden University Medical Center · unknown · Colorectal Cancer · principal investigator
- Ph2NCT01110785 · Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal CancerLeiden University Medical Center · unknown · Colorectal Cancer · principal investigator
- Ph2NCT00410462 · Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaEuropean Organisation for Research and Treatment of Cancer - EORTC · unknown · Ovarian Cancer, Sarcoma, Small Intestine Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:08 UTC. The ranking covers the 200 most relevant of 172 PubMed records, and a shared surname and initials can bring in a namesake. All 172 on PubMed
- Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet · 20121,700 citationsRCR 48.7
- 1,120 citationsRCR 30.4
- 974 citationsRCR 30.9
- Combination chemotherapy in advanced adrenocortical carcinoma.N Engl J Med · 2012674 citationsRCR 19.4
- 591 citationsRCR 21.6
- Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.Eur J Cancer · 2019549 citationsRCR 25.1
- 432 citationsRCR 15.6
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.Lancet · 2019400 citationsRCR 13.4
- 398 citationsRCR 23.5
- 335 citationsRCR 11.4